Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin

NCT00131235 is registered in ClinicalTrials.gov with Tampere University as lead sponsor.

NCT NCT00131235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00131235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin
Lead sponsor
Tampere University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 31, 2003
Completion date
December 31, 2027
Enrollment
1,320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, pregnancy, preterm birth, sexually transmitted diseases